FCMI
Foresite Capital Management III Portfolio holdings
AUM
$37.9M
This Quarter Return
-14.5%
1 Year Return
-6.87%
3 Year Return
+443.49%
5 Year Return
+535.97%
10 Year Return
–
AUM
$94.3M
AUM Growth
+$94.3M
(-17%)
Cap. Flow
+$0
Cap. Flow
% of AUM
0%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
8
New
–
Increased
–
Reduced
–
Closed
–
Top Buys
No buys this quarter
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Aclaris Therapeutics
ACRS
$209M
| $34.3M | 36.39% |
1,954,904
| – | – |
|
2
Natera
NTRA
$23.1B
| $14.5M | 15.32% |
127,305
| – | – |
|
|
XLRN
3
DELISTED
Acceleron Pharma Inc.
XLRN
| $13.6M | 14.45% |
108,630
| – | – |
|
|
EPZM
4
DELISTED
Epizyme, Inc
EPZM
| $8.3M | 8.79% |
998,278
| – | – |
|
5
FibroGen
FGEN
$47.8M
| $8.14M | 8.63% |
305,784
| – | – |
|
|
VRNA
6
Verona Pharma
VRNA
$9.16B
| $7.27M | 7.7% |
1,111,112
| – | – |
|
|
CBAY
7
DELISTED
Cymabay Therapeutics
CBAY
| $7.16M | 7.59% |
1,641,804
| – | – |
|
8
Novavax
NVAX
$1.21B
| $1.06M | 1.13% |
5,000
| – | – |
|